|
|||
| CMS Expands Scope of NCA for FDG PET for Oncology Indications and Solicits Public Comments September 23, 2008 The Centers for Medicare and Medicaid Services (CMS) posted an announcement changing the name and broadening the scope of the National Coverage Analysis (NCA) Tracking Sheet for FDG PET for brain, cervical, ovarian, pancreatic, small cell lung and testicular cancers (CAG-00181R) to NCA Tracking Sheet for Positron Emission Tomography (FDG) for Solid Tumors (CAG-00181R) and is soliciting public comments. In the announcement CMS states: We have received public input indicating that the current coverage framework which required cancer by cancer consideration of diagnosis, staging, restaging and monitoring response to treatment should be replaced by a more omnibus consideration. Though that coverage framework has been useful, we are open to public input that it be retired and that a general policy could be developed and applied to oncologic FDG PET imaging. The following sections of the National Coverage Determination Manual currently address solid tumors:
We have broadened the scope of this review and are soliciting additional public comment on the use of FDG PET imaging for other solid tumors. We are also soliciting public suggestions for possible alternatives to the current coverage framework described above. The public comment period is from September 16, 2008 through October 16, 2008. The NCA tracking sheet, PET for Solid Tumors, can be found at: www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=218 To submit comments use the orange “Comment” button at the top of the page. NCA Decision due dates: The proposed decision memo due date is January 10, 2009. The expected NCA completion date (i.e. final decision) is April 9, 2009.
Reimbursement information is provided by Cardinal Health as general coding and payment information. This information is not intended to replace or serve as substitute for your duty to verify that such information is proper for your particular circumstances. Any codes reported should accurately reflect the procedures performed and the patient’s conditions. You may want to consult with local payers to confirm compliance with local policies, or otherwise review and confirm reimbursement policies with your own legal or other professional advisors. |
